nach oben

European Journal of Nutrition

Erschienen in:

10.03.2017 | Original Contribution

Antiproliferative activity of vitexin-2-O-xyloside and avenanthramides on CaCo-2 and HepG2 cancer cells occurs through apoptosis induction and reduction of pro-survival mechanisms

verfasst von: Emanuele Salvatore Scarpa, Elena Antonini, Francesco Palma, Michele Mari, Paolino Ninfali

Erschienen in: European Journal of Nutrition | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

CaCo-2 colon cancer cells and HepG2 liver cancer cells represent two malignant cell lines, which show a high resistance to apoptosis induced by the conventional anticancer drugs. Vitexin-2-O-xyloside (XVX) and avenanthramides (AVNs) are naturally occurring dietary agents from Beta vulgaris var. cicla L. and Avena sativa L., respectively. The aim of this work was to evaluate the antiproliferative effects and the reduction of the pro-survival mechanisms exerted by XVX and AVNs, used individually and in combination, in CaCo-2 and HepG2 cancer cells.

Methods

XVX and AVNs were isolated by liquid chromatography and characterized by HPLC–PDA–MS. The XVX and AVN antiproliferative effects were evaluated through sulforhodamine B method, while their pro-apoptotic effects through caspase activity assays. RTqPCR was used to investigate the modulation of the pro-survival factors baculoviral inhibitor of apoptosis repeat-containing 5 (BIRC5), hypoxia inducible factor 1 A (HIF1A), and vascular endothelial growth factor A (VEGFA). Cellular antioxidant activity (CAA) was investigated by means of DCFH-DA assay, whereas chemical antioxidant capacity was evaluated by the ORAC method.

Results

XVX and AVNs, both individually and in combination, inhibited the proliferation of CaCo-2 and HepG2 cancer cells, through activation of caspases 9, 8, and 3. XVX and AVNs downregulated the pro-survival genes BIRC5, HIF1A, and VEGFA. The CAA assay showed that AVNs exhibited strong antioxidant activity inside both CaCo-2 and HepG2 cells.

Conclusions

The antiproliferative activity of the XVX + AVNs mixture represents an innovative treatment, which is effective against two types of cancer cells characterized by high resistance to the conventional anticancer drugs.

Nur mit Berechtigung zugänglich

Ninfali P, Bacchiocca M, Antonelli A, Biagiotti E, Di Gioacchino AM, Piccoli G, Stocchi V, Brandi G (2007) Characterization and biological activity of the main flavonoids from Swiss Chard (Beta vulgaris subspecies cycla). Phytomedicine 14:216–221CrossRefPubMed

Ninfali P, Angelino D (2013) Nutritional and functional potential of Beta vulgaris cicla and rubra. Fitoterapia 89:188–199CrossRefPubMed

Gennari L, Felletti M, Blasa M, Angelino D, Celeghini C, Corallini A, Ninfali P (2011) Total extract of Beta vulgaris var. cicla seeds versus its purified phenolic components: antioxidant activities and antiproliferative effects against colon cancer cells. Phytochem Anal 22:272–279CrossRefPubMed

Papi A, Farabegoli F, Iori R, Orlandi M, De Nicola GR, Bagatta M, Angelino D, Gennari L, Ninfali P (2013) Vitexin-2-0-xyloside, raphasatin and (–)-epigallocatechin-3-gallate synergistically affect cell growth and apoptosis of colon cancer cells. Food Chem 138:1521–1530CrossRefPubMed

Farabegoli F, Scarpa ES, Frati A, Serafini G, Papi A, Spisni E, Antonini E, Benedetti S, Ninfali P (2017) Betalains increase vitexin-2-O-xyloside cytotoxicity in CaCo-2 cancer cells. Food Chem 218:356–364CrossRefPubMed

Peterson DM (2001) Oat antioxidants. J Cereal Sci 33:115–129CrossRef

Collins FW (1989) Oat phenolics: avenanthramides, novel substituted N-cinnamoylanthranilate alkaloids from oat groats and hulls. J Agric Food Chem 37:60–66CrossRef

Antonini E, Lombardi F, Alfieri M, Diamantini G, Redaelli R, Ninfali P (2016) Nutritional characterization of naked and dehulled oat cultivar samples at harvest and after storage. J Cereal Sci 72:46–53CrossRef

Skoglund M, Peterson DM, Andersson R, Nilsson J, Dimberg LH (2008) Avenanthramide content and related enzyme activities in oats as affected by steeping and germination. J Cereal Sci 48:294–303CrossRef

10.

Xu JG, Tian CR, Hu QP, Luo JY, Wang XD, Tian XD (2009) Dynamic changes in phenolic compounds and antioxidant activity in oats (Avena nuda L.) during steeping and germination. J Agric Food Chem 57:10392–10398CrossRefPubMed

11.

Chen CY, Milbury PE, Kwak HK, Collins FW, Samuel P, Blumberg JB (2004) Avenanthramides and phenolic acids from oats are bioavailable and act synergistically with vitamin C to enhance hamster and human LDL resistance to oxidation. J Nutr 134:1459–1466CrossRefPubMed

12.

Chen CYO, Milbury PE, Collins FW, Blumberg JB (2007) Avenanthramides are bioavailable and have antioxidant activity in humans after acute consumption of an enriched mixture from oats. J Nutr 137:1375–1382CrossRefPubMed

13.

Koenig RT, Dickman JR, Wise ML, Ji LL (2011) Avenanthramides are bioavailable and accumulate in hepatic, cardiac, and skeletal muscle tissue following oral gavage in rats. J Agric Food Chem 59:6438–6443CrossRefPubMed

14.

Meydani M (2009) Potential health benefits of avenanthramides of oats. Nutr Rev 67:731–735CrossRefPubMed

15.

Guo WM, Nie L, Wu DY, Wise ML, Collins FW, Meydani SN, Meydani M (2010) Avenanthramides inhibit proliferation of human colon cancer cell lines in vitro. Nutr Cancer 62:1007–1016CrossRefPubMed

16.

Holdenrieder S, Stieber P (2004) Apoptotic markers in cancer. Clin Biochem 37:605–617CrossRefPubMed

17.

Samali A, Jager R (2014) Mechanisms of resistance to cell death pathways in cancer cells. In: McManus LM, Mitchell RN (eds) Pathobiology of human disease, 1st edn. Elsevier Inc., Atlanta, pp 393–402CrossRef

18.

Altieri DC (2013) Targeting survivin in cancer. Cancer Lett 332:225–228CrossRefPubMed

19.

Johnson ME, Howerth EW (2004) Survivin: a bifunctional inhibitor of apoptosis protein. Vet Pathol 41:599–607CrossRefPubMed

20.

Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674CrossRef

21.

Gomez-Roman N, Sahasrabudhe NM, McGregor F, Chalmers AJ, Cassidy J, Plumb J (2016) Hypoxia-inducible factor 1 alpha is required for the tumourigenic and aggressive phenotype associated with Rab25 expression in ovarian cancer. Oncotarget 7:22650–22664CrossRefPubMedPubMedCentral

22.

Brahimi-Horn MC, Chiche J, Pouyssegur J (2007) Hypoxia and cancer. J Mol Med 85:1301–1307CrossRefPubMed

23.

Wang GL, Jiang BH, Rue EA, Semenza GL (1995) Hypoxia-inducible factor-1 is a basic-helix–loop–helix-pas heterodimer regulated by cellular O-2 tension. Proc Natl Acad Sci USA 92:5510–5514CrossRefPubMed

24.

Baba Y, Nosho K, Shima K, Irahara N, Chan AT, Meyerhardt JA, Chung DC, Giovannucci EL, Fuchs CS, Ogino S (2010) HIF1A overexpression is associated with poor prognosis in a cohort of 731 colorectal cancers. Am J Pathol 176:2292–2301CrossRefPubMedPubMedCentral

25.

Ferrara N (2005) VEGF as a therapeutic target in cancer. Int Soc Cell 69:11–16

26.

Ellis LM, Takahashi Y, Liu W, Shaheen RM (2000) Vascular endothelial growth factor in human colon cancer: biology and therapeutic implications. Oncologist 5:11–15CrossRefPubMed

27.

Doll JA, Hobbs JE, Soff JA (2007) Role of apoptosis in anti-angiogenic cancer therapies. In: Gewirtz DA, Holt SE, Grant S (eds) Apoptosis and senescence in cancer chemotherapy and radiotherapy, 2nd edn. Humana Press, Totowa, pp 537–555

28.

Piccirillo S, Filomeni G, Brune B, Rotilio G, Ciriolo MR (2009) Redox mechanisms involved in the selective activation of Nrf2-mediated resistance versus p53-dependent apoptosis in adenocarcinoma cells. J Biol Chem 284:27721–27733CrossRefPubMedPubMedCentral

29.

Heo SH, Kwak J, Jang KL (2015) All-trans retinoic acid induces p53-dependent apoptosis in human hepatocytes by activating p14 expression via promoter hypomethylation. Cancer Lett 362:139–148CrossRefPubMed

30.

Ye RP, Chen ZD (2017) Saikosaponin A, an active glycoside from Radix bupleuri, reverses P-glycoprotein-mediated multidrug resistance in MCF-7/ADR cells and HepG2/ADM cells. Xenobiotica 47:176–184CrossRefPubMed

31.

Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P (2007) Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18:581–592CrossRefPubMed

32.

Liu LP, Zubik L, Collins FW, Marko M, Meydani M (2004) The antiatherogenic potential of oat phenolic compounds. Atherosclerosis 175:39–49CrossRefPubMed

33.

Ninfali P, Gennari L, Biagiotti E, Cangi F, Mattoli L, Maidecchi A (2009) Improvement in botanical standardization of commercial freeze-dried herbal extracts by using the combination of antioxidant capacity and constituent marker concentrations. J AOAC Int 92:797–805PubMed

34.

Wang Y, Tang Q, Jiang S, Li M, Wang X (2013) Anti-colorectal cancer activity of macrostemonoside A mediated by reactive oxygen species. Biochem Biophys Res Commun 441:825–830CrossRef

35.

Scarpa ES, Emanuelli M, Frati A, Pozzi V, Antonini E, Diamantini G, Di RG, Sartini D, Armeni T, Palma F, Ninfali P (2016) Betacyanins enhance vitexin-2-O-xyloside mediated inhibition of proliferation of T24 bladder cancer cells. Food Funct 7:4772–4780CrossRefPubMed

36.

Peterson DM, Hahn MJ, Emmons CL (2002) Oat avenanthramides exhibit antioxidant activities in vitro. Food Chem 79:473–478CrossRef

37.

Khan N, Adhami VM, Mukhtar H (2008) Apoptosis by dietary agents for prevention and treatment of cancer. Biochem Pharmacol 76:1333–1339CrossRefPubMedPubMedCentral

38.

Huang H, Chen AY, Rojanasakul Y, Ye X, Rankin GO, Chen YC (2015) Dietary compounds galangin and myricetin suppress ovarian cancer cell angiogenesis. J Funct Foods 15:464–475CrossRefPubMedPubMedCentral

39.

Angelino D, Berhow M, Ninfali P, Jeffery EH (2013) Caecal absorption of vitexin-2-O-xyloside and its aglycone apigenin, in the rat. Food Funct 4:1339–1345CrossRefPubMed

40.

Gorrini C, Harris IS, Mak TW (2013) Modulation of oxidative stress as an anticancer strategy. Nat Rev Drug Discov 12:931–947CrossRefPubMed

41.

Arbiser JL, Petros J, Klafter R, Govindajaran B, McLaughlin ER, Brown LF, Cohen C, Moses M, Kilroy S, Arnold RS, Lambeth JD (2002) Reactive oxygen generated by Nox1 triggers the angiogenic switch. Proc Natl Acad Sci USA 99:715–720CrossRefPubMed

42.

Zhang Y, Zhao W, Zhang HJ, Domann FE, Oberley LW (2002) Overexpression of copper zinc superoxide dismutase suppresses human glioma cell growth. Cancer Res 62:1205–1212PubMed

43.

Ueda S, Nakamura H, Masutani H, Sasada T, Takabayashi A, Yamaoka Y, Yodoi J (2002) Baicalin induces apoptosis via mitochondrial pathway as prooxidant. Mol Immunol 38:781–791CrossRefPubMed

44.

Ismail N, Alam M (2001) A novel cytotoxic flavonoid glycoside from Physalis angulata. Fitoterapia 72:676–679CrossRefPubMed

45.

Cao G, Sofic E, Prior RL (1997) Antioxidant and prooxidant behavior of flavonoids: structure–activity relationships. Free Radic Biol Med 22:749–760CrossRefPubMed

46.

Choi HJ, Eun JS, Kim BG, Kim SY, Jeon H, Soh Y (2006) Vitexin, an HIF-1alpha inhibitor, has anti-metastatic potential in PC12 cells. Mol Cells 22:291–299PubMed

47.

Ma J, Feng Y, Liu Y, Li X (2016) PUMA and survivin are involved in the apoptosis of HepG2 cells induced by microcystin-LR via mitochondria-mediated pathway. Chemosphere 157:241–249CrossRefPubMed

48.

Harris IS, Brugge JS (2015) Cancer: the enemy of my enemy is my friend. Nature 527:170–171CrossRefPubMed

Titel: Antiproliferative activity of vitexin-2-O-xyloside and avenanthramides on CaCo-2 and HepG2 cancer cells occurs through apoptosis induction and reduction of pro-survival mechanisms
verfasst von: Emanuele Salvatore Scarpa
Elena Antonini
Francesco Palma
Michele Mari
Paolino Ninfali
Publikationsdatum: 10.03.2017
Verlag: Springer Berlin Heidelberg
Erschienen in: European Journal of Nutrition / Ausgabe 4/2018
Print ISSN: 1436-6207
Elektronische ISSN: 1436-6215
DOI: https://doi.org/10.1007/s00394-017-1418-y

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

24.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Antiproliferative activity of vitexin-2-O-xyloside and avenanthramides on CaCo-2 and HepG2 cancer cells occurs through apoptosis induction and reduction of pro-survival mechanisms

Abstract

Purpose

Methods

Results

Conclusions

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Metformin rückt in den Hintergrund

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Thrombophiliescreening – Wenn, dann richtig und nur bei therapeutischer Konsequenz

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Update Innere Medizin

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2018

Overweight and diabetes prevention: is a low-carbohydrate–high-fat diet recommendable?

miR-124a expression contributes to the monophasic pattern of insulin secretion in islets from pregnant rats submitted to a low-protein diet

Alcohol and red wine consumption, but not fruit, vegetables, fish or dairy products, are associated with less endothelial dysfunction and less low-grade inflammation: the Hoorn Study

The sensitivity and specificity of thyroglobulin concentration using repeated measures of urinary iodine excretion

Yogurt consumption, body composition, and metabolic health in the Québec Family Study

Methyl-donor depletion of head and neck cancer cells in vitro establishes a less aggressive tumour cell phenotype

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Metformin rückt in den Hintergrund

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Thrombophiliescreening – Wenn, dann richtig und nur bei therapeutischer Konsequenz

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Update Innere Medizin